Spotlight: Oracle Chairman Buys Stake in SuperGen
Larry Ellison, chairman of software company Oracle Corp., on Tuesday purchased a 9% stake in drug company SuperGen Inc., which is working to develop a new generation of cancer drugs. Oracle was not immediately available to explain the $15-million purchase, but a spokesman for San Ramon-based SuperGen said: “Larry has an interest in cancer, especially prostate cancer. A lot of his close friends like Michael Milken and [Intel Chairman] Andy Grove have had bouts with it.”
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.